Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Pictilisib | pan PI3K | PI3K/mTOR | 1.1555 | 0.0345 | 0.3109 | 0.0488 | 0.4397 | 14.0561 | 0.97858 |
HCC1954 | Ipatasertib | AKT | PI3K/mTOR | 1.4342 | 0.2509 | 0.2145 | 0.0288 | 0.9249 | 0.80694 | 0.98539 |
HCC1954 | Alpelisib | PI3Ka | PI3K/mTOR | 1.2292 | -0.3408 | 0.2652 | 0.1073 | 0.8509 | 4.4679 | 0.99224 |
HCC1954 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.0070107 | -0.3632 | 0.9490 | 0.3748 | 1.0954 | 0.010784 | 0.99379 |
HCC1954 | TGX221 | PI3Kb | PI3K/mTOR | Inf | 0.9607 | -0.0374 | -0.0050 | 0.0000 | Inf | -1.0282 |
HCC1954 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0096629 | -0.3280 | 0.5536 | 0.1704 | 0.7380 | 0.018218 | 0.98125 |
HCC1954 | Everolimus | mTOR1 | PI3K/mTOR | Inf | 0.3263 | 0.6531 | 0.1358 | 0.0000 | Inf | 0.52018 |
HCC1954 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.014251 | -0.0830 | 0.5651 | 0.1455 | 1.3479 | 0.013876 | 0.98856 |
HCC1954 | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.8349 | -0.0093 | -0.0064 | 1.3800 | 7.2097 | 0.65841 |
HCC1954 | Buparlisib | pan PI3K | PI3K/mTOR | 0.52073 | -0.4576 | 0.4002 | 0.1883 | 1.6194 | 0.7982 | 0.9975 |
HCC1954 | Pictilisib | pan PI3K | PI3K/mTOR | 0.94449 | -0.2272 | 0.3087 | 0.1077 | 0.8502 | 2.3595 | 0.9976 |
HCC70 | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.9348 | -0.0227 | 0.0035 | 0.0000 | Inf | 0.040075 |
HCC70 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0048011 | -0.1620 | 0.7024 | 0.0912 | 1.1840 | 0.0050026 | 0.97794 |
HCC70 | Everolimus | mTOR1 | PI3K/mTOR | 0.24351 | 0.3727 | 0.4764 | 0.0448 | 0.1135 | 51.0339 | 0.79604 |
HCC70 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0058452 | -0.5550 | 0.6451 | 0.1234 | 0.5307 | 0.026938 | 0.94991 |
HCC70 | TGX221 | PI3Kb | PI3K/mTOR | 0.092754 | 0.0049 | 0.4729 | 0.0591 | 0.8818 | 0.076452 | 0.9787 |
HCC70 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 0.15092 | -0.6846 | 0.5796 | 0.1546 | 0.7043 | 0.64661 | 0.98584 |
HCC70 | Alpelisib | PI3Ka | PI3K/mTOR | 4.4987 | 0.0981 | 0.1182 | 0.0196 | 1.0448 | 12.8744 | 0.95143 |
HCC70 | Ipatasertib | AKT | PI3K/mTOR | 0.1397 | -0.2624 | 0.4974 | 0.0860 | 0.8534 | 0.21677 | 0.98567 |
Hs 578T | Buparlisib | pan PI3K | PI3K/mTOR | 0.68631 | -0.3434 | 0.3760 | 0.1520 | 1.4596 | 1.0562 | 0.9918 |
Hs 578T | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.9143 | 0.0252 | 0.0005 | 2.0096 | 0.1778 | 0.76824 |
Hs 578T | INK-128 | mTORC1/2 | PI3K/mTOR | 0.0090588 | -0.0708 | 0.6226 | 0.1010 | 1.2366 | 0.0087974 | 0.98428 |
Hs 578T | Everolimus | mTOR1 | PI3K/mTOR | 0.0056053 | 0.4204 | 0.5273 | 0.0278 | 0.4084 | 2.87e-05 | 0.64462 |
Hs 578T | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.0070774 | -0.2174 | 0.5683 | 0.1373 | 0.7608 | 0.010409 | 0.98427 |
Hs 578T | TGX221 | PI3Kb | PI3K/mTOR | 34.4921 | 0.7094 | 0.0668 | 0.0103 | 0.5623 | 243.351 | 0.9333 |